Peer review articles 2006

234.     Sehouli J., Stupin jH, Schlieper U, Kümmel S, Henrich W, Dietel W, Lichtenegger W: Actinomycotic inflammatory disease and misdiagnosis of ovarian cancer: A case report. Anticancer Research 26: 1727-1723, 2006

235.     Gyorffy B, Surowiak P, Kiesslich O, Denkert C, Schafer R, Dietel M, Lage H: Gene expression profiling of 30 cancer cell lines predicts resistance towards 11 anticancer drugs at clinically achieved concentrations. Int J Cancer. 2006;118:1699-712.

236.     Surowiak P, Materna V, Maciejczyk A, Pudelko M, Markwitz E, Spaczynski M, Dietel M, Zabel M, Lage H: Nuclear metallothionein expression correlates with cisplatin resistance of ovarian cancer cells and poor clinical outcome. Virchows Archiv 2007 Jan 19.

237.     Materna V, Surowiak P, Kaplenko I, Spaczynski M, Duan Z, Zabel M, Dietel M, Lage H: Taxol-resistance-associated-gene-3 (TRAG-3/CSAG2) expression is predictive for clinical outcome in ovarian carcinoma patients. Virchows Arch 2007 Jan 10

238.     Surowiak P, Materna V, Maciejczyk A, Kaplenko I, Spaczynski M, Dietel M, Lage H, Zabel M: CD46 expression is indicative of shorter revival-free survival for ovarian cancer patients. Anticancer Res. 2006 Nov-Dec;26(6C):4943-8.

239.     Surowiak P, Materna V, Kaplenko I, Spaczynski M, Dolinska-Krajewska B, Gebarowska E, Dietel M, Zabel M, Lage H: ABCC2 (MRP2, cMOAT) can be localized in the nuclear membrane of ovarian carcinomas and correlates with resistance to cisplatin and clinical outcome. Clin Cancer Res. 2006 Dec 1;12(23):7149-58.

240.     Fritzsche FR, Kristiansen G, Boesl A, Burkhardt M, Pahl S, Dankof A, Dietel M, Dahl E: Tissue pretreatment with formic acid might lower HercepTest scores in breast cancer. Diagn Mol Pathol. 2006 Dec;15(4):237-42.

241.     Denkert C, Budczies J, Kind T, Weichert W, Tablack P, Sehouli J, Niesporek S, Konsgen D, Dietel M, Fiehn O: Mass spectrometry-based metabolic profiling reveals different metabolite patterns in invasive ovarian carcinomas and ovarian borderline tumors. Cancer Res. 2006 Nov 15;66(22):10795-804.

242.     Fritzsche FR, Jung M, Xu C, Rabien A, Schicktanz H, Stephan C, Dietel M, Jung K, Kristiansen G: ADAM8 expression in prostate cancer is associated with parameters of unfavorable prognosis. Virchows Arch. 2006 Dec;449(6):628-36.

243.     Schrader T, Niepage S, Leuthold T, Saeger K, Schluns K, Hufnagl P, Kayser K, Dietel M: The diagnostic path, a useful visualisation tool in virtual microscopy. Diagn Pathol. 2006 Nov 8;1:40.

244.     Kristiansen G, Jacob J, Buckendahl AC, Grutzmann R, Alldinger I, Sipos B, Kloppel G, Bahra M, Langrehr JM, Neuhaus P, Dietel M, Pilarsky C: Peroxisome proliferator-activated receptor gamma is highly expressed in pancreatic cancer and is associated with shorter overall survival times. Clin Cancer Res. 2006 Nov 1;12(21):6444-51.

245.     Surowiak P, Drag M, Materna V, Suchocki S, Grzywa R, Spaczynski M, Dietel M, Oleksyszyn J, Zabel M, Lage H: Expression of aminopeptidase N/CD13 in human ovarian cancers. Int J Gynecol Cancer. 2006 Sep-Oct;16(5):1783-8.

246.     Fritzsche FR, Pahl S, Petersen I, Burkhardt M, Dankof A, Dietel M, Kristiansen G: Anaplastic large-cell non-Hodgkin's lymphoma of the breast in periprosthetic localisation 32 years after treatment for primary breast cancer-a case report. Virchows Arch. 2006;449:561-4.

247.     Surowiak P, Materna V, Gyorffy B, Matkowski R, Wojnar A, Maciejczyk A, Paluchowski P, Dziegiel P, Pudelko M, Kornafel J, Dietel M, Kristiansen G, Zabel M, Lage H: Multivariate analysis of oestrogen receptor alpha, pS2, metallothionein and CD24 expression in invasive breast cancers. Br J Cancer. 2006;95:339-46.

248.     Gyorffy A, Vasarhelyi B, Szoke D, Dietel M, Tulassay T, Gyorffy B: Comparative promoter analysis of doxorubicin resistance-associated genes suggests E47 as a key regulatory element. Anticancer Res. 2006;26:2971-6.

249.     Fritzsche FR, Dietel M, Kristiansen G: Flat epithelial neoplasia and other columnar cell lesions of the breast. Pathologe. 2006;27:381-6.

250.     Krukemeyer MG, V D Driesch C, Dankof A, Krenn V, Hansen D, Dietel M: [Necessity of increasing autopsy frequency following the introduction of DRGs. Pathologe. 2007; 28: 294-298.

251.     Denkert C, Koch I, von Keyserlingk N, Noske A, Niesporek S, Dietel M, Weichert W: Expression of the ELAV-like protein HuR in human colon cancer: association with tumor stage and cyclooxygenase-2. Mod Pathol. 2006;19:1261-9.

252.     Dietel M: Können Östrogen Mammakarzinome initiieren? Frauenarzt, 47 :435-439

253.     Dietel M, Sers C: Personalized medicine and development of targeted therapies: The upcoming challenge for diagnostic molecular pathology. A review. Virchows Arch. 2006;448: 744-55. Review.

254.     Surowiak P, Materna V, Kaplenko I, Spaczynski M, Dietel M, Kristiansen G, Lage H, Zabel M: Unfavourable prognostic value of CD24 expression in sections from primary and relapsed ovarian cancer tissue. Int J Gynecol Cancer. 2006;16:515-21.